Ulta Beauty Sales Momentum Builds As K-Beauty Expansion And Fewer Discounts Drive Growth

J.P. Morgan has raised Ulta Beauty's price target to $600 from $525, maintaining an Overweight rating, driven by expectations of stronger comparable sales (4.8% Q2 forecast), higher EPS, and valuation upside from improved promotional effectiveness and product innovation. This bullish outlook, which includes projected 2027 EPS of $31.64, is largely echoed across the analyst community, with Barclays, Oppenheimer, Canaccord, and DA Davidson also recently lifting their price targets for ULTA, signaling broadly constructive sentiment ahead of the company's Q2 earnings report.

Analysis

Analyst sentiment for Ulta Beauty (ULTA) has turned decisively positive ahead of its Q2 earnings report, led by a significant price target increase from J.P. Morgan to $600 from $525. This upgrade is underpinned by specific, data-driven factors, including a revised Q2 comparable sales forecast of 4.8%, which is nearly double the street consensus of 2.5%, and is supported by Nielsen/Circana data trends showing 4%-6% growth. The bullish thesis also rests on operational improvements such as more effective, targeted promotions that exclude prestige categories and a substantial acceleration in product innovation, which has nearly quadrupled year-over-year. This positive outlook is echoed by a chorus of other firms, with Barclays, Oppenheimer, Canaccord, and DA Davidson all raising their price targets in the last month, creating a strong consensus. J.P. Morgan's long-term view projects robust earnings growth, with EPS estimates of $24.85 for 2025 and $31.64 for 2027, justifying a premium valuation of 19x its 2027 EPS estimate. While Wells Fargo maintains an Underweight rating, its own price forecast was also raised, suggesting that even bears see improved fundamentals.

Key Decisions for Investors

• Given the strong, multi-firm analyst consensus and upward revisions based on fundamental improvements, investors should re-evaluate their positions for potential upside leading into the August 28 earnings call.
• The upcoming earnings report is a critical catalyst; focus specifically on whether comparable sales meet or exceed J.P. Morgan's 4.8% forecast and if management delivers a substantial upgrade to full-year guidance.
• Be mindful that heightened expectations and a premium valuation are now priced in, meaning any failure to meet the elevated forecasts for sales growth and profitability could trigger a significant stock correction.